A business in context
CYTK research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Common Stock | 188.0 | 44.36 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Common Stock | 822.0 | 44.36 |
| 2026-06-29 | Lee Sung | S · Sale | Common Stock | 3134.0 | 85.0 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Common Stock | 188.0 | 44.36 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Common Stock | 823.0 | 44.36 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Common Stock | 1113.0 | 48.51 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Incentive Stock Option (Right to Buy) | 188.0 | 0.0 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 822.0 | 0.0 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Incentive Stock Option (Right to Buy) | 188.0 | 0.0 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 1113.0 | 0.0 |
| 2026-06-29 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 823.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 23370.0 | 48.51 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 9307.0 | 44.36 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 2817.0 | 44.36 |
| 2026-06-24 | Lee Sung | S · Sale | Common Stock | 38730.0 | 82.3 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 1113.0 | 48.51 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 822.0 | 44.36 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 1113.0 | 48.51 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Common Stock | 188.0 | 44.36 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 1113.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Incentive Stock Option (Right to Buy) | 2817.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 822.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Incentive Stock Option (Right to Buy) | 188.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 1113.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 23370.0 | 0.0 |
| 2026-06-24 | Lee Sung | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 9307.0 | 0.0 |
| 2026-06-23 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 79.51 |
| 2026-06-23 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-06-23 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-06-15 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 70.46 |
| 2026-06-09 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-06-09 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 67.98 |
| 2026-06-09 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-06-01 | Kaye Edward M. MD | S · Sale | Common Stock | 2933.0 | 76.09 |
| 2026-06-01 | Callos Andrew | M · Exercise / conversion | Common Stock | 15000.0 | 23.26 |
| 2026-06-01 | Callos Andrew | S · Sale | Common Stock | 15000.0 | 74.08 |
| 2026-06-01 | Callos Andrew | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 15000.0 | 0.0 |
| 2026-06-01 | PARSHALL B LYNNE | S · Sale | Common Stock | 5000.0 | 74.08 |
| 2026-05-27 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 77.21 |
| 2026-05-27 | Bhanji Muna | A · Grant / award | Common Stock | 2851.0 | 0.0 |
| 2026-05-27 | Bhanji Muna | A · Grant / award | Non-Qualified Stock Option (Right to Buy) | 4301.0 | 0.0 |
| 2026-05-27 | Daly James M | A · Grant / award | Common Stock | 2851.0 | 0.0 |
| 2026-05-27 | Daly James M | A · Grant / award | Non-Qualified Stock Option (Right to Buy) | 4301.0 | 0.0 |
| 2026-05-27 | Harrington Robert Arthur | A · Grant / award | Common Stock | 2851.0 | 0.0 |
| 2026-05-27 | Harrington Robert Arthur | A · Grant / award | Non-Qualified Stock Option (Right to Buy) | 4301.0 | 0.0 |
| 2026-05-27 | HENDERSON JOHN T | A · Grant / award | Common Stock | 2851.0 | 0.0 |
| 2026-05-27 | HENDERSON JOHN T | A · Grant / award | Non-Qualified Stock Option (Right to Buy) | 4301.0 | 0.0 |
| 2026-05-27 | Kaye Edward M. MD | A · Grant / award | Common Stock | 2851.0 | 0.0 |
| 2026-05-27 | Kaye Edward M. MD | A · Grant / award | Non-Qualified Stock Option (Right to Buy) | 4301.0 | 0.0 |
| 2026-05-27 | PARSHALL B LYNNE | A · Grant / award | Common Stock | 2851.0 | 0.0 |
Identity & relationships
SEC issuer · 0001061983CYTOKINETICS INC
Search names and former names
View Wikidata identity and references ↗
- Cytokinetics · alias · wikidata
- Cytokinetics (United States) · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $18.47M | $19.66M |
| 2023-12-31 | $7.53M | $8.25M |
| 2022-12-31 | $94.59M | $107.91M |
| 2021-12-31 | $70.43M | $86.77M |
| 2020-12-31 | $55.83M | $72.03M |
| 2019-12-31 | $26.87M | $35.09M |
| 2018-12-31 | $31.50M | $41.89M |
| 2017-12-31 | $13.37M | $18.21M |